Themis Medicare Faces Persistent Decline Amidst Significant Financial Challenges

Themis Medicare, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, hitting a new 52-week low of Rs. 98. This decline marks a continued trend, as the stock has underperformed its sector by 2.03% and has seen a consecutive fall over the past six days, resulting in a total drop of 6.83%.
The company's performance metrics reveal a concerning picture. Over the past year, Themis Medicare has recorded a staggering decline of 61.14%, contrasting sharply with the Sensex's modest drop of 2.83%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend.

Financial results have also been troubling, with operating profit declining at an annual rate of 138.71% over the last five years. The latest quarterly results showed a significant drop in profit after tax, falling by 290.7% compared to the previous four-quarter average. Despite these challenges, the company maintains a low Debt to EBITDA ratio of 1.16 times, suggesting some capacity to manage its debt obligations. Overall, Themis Medicare's recent performance underscores a challenging landscape for the company.